nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—SLC6A3—malignant glioma	0.485	1	CbGaD
Mirtazapine—CYP1A2—Carmustine—malignant glioma	0.0624	0.569	CbGbCtD
Mirtazapine—CYP3A4—Temozolomide—malignant glioma	0.0472	0.43	CbGbCtD
Mirtazapine—HTR3A—fourth ventricle—malignant glioma	0.015	0.113	CbGeAlD
Mirtazapine—HTR2C—choroid plexus—malignant glioma	0.0119	0.0896	CbGeAlD
Mirtazapine—DRD3—telencephalic ventricle—malignant glioma	0.00627	0.0472	CbGeAlD
Mirtazapine—HTR2A—choroid plexus—malignant glioma	0.00597	0.0449	CbGeAlD
Mirtazapine—SLC6A3—telencephalic ventricle—malignant glioma	0.00361	0.0271	CbGeAlD
Mirtazapine—HTR2C—telencephalic ventricle—malignant glioma	0.00349	0.0262	CbGeAlD
Mirtazapine—HTR7—pons—malignant glioma	0.00341	0.0257	CbGeAlD
Mirtazapine—HTR2A—cerebellar cortex—malignant glioma	0.00301	0.0226	CbGeAlD
Mirtazapine—Hyperacusis—Temozolomide—malignant glioma	0.00298	0.0191	CcSEcCtD
Mirtazapine—HTR1A—telencephalic ventricle—malignant glioma	0.00293	0.0221	CbGeAlD
Mirtazapine—HTR7—telencephalic ventricle—malignant glioma	0.0028	0.0211	CbGeAlD
Mirtazapine—Paranoid reaction—Carmustine—malignant glioma	0.0027	0.0174	CcSEcCtD
Mirtazapine—Impaired healing—Carmustine—malignant glioma	0.00265	0.0171	CcSEcCtD
Mirtazapine—DRD2—telencephalic ventricle—malignant glioma	0.00265	0.02	CbGeAlD
Mirtazapine—HRH3—brainstem—malignant glioma	0.00245	0.0184	CbGeAlD
Mirtazapine—Grand mal convulsion—Carmustine—malignant glioma	0.00241	0.0155	CcSEcCtD
Mirtazapine—Tongue discolouration—Temozolomide—malignant glioma	0.00229	0.0148	CcSEcCtD
Mirtazapine—Cerebral ischaemia—Temozolomide—malignant glioma	0.00229	0.0148	CcSEcCtD
Mirtazapine—HRH3—telencephalon—malignant glioma	0.00217	0.0163	CbGeAlD
Mirtazapine—HTR2A—pons—malignant glioma	0.00212	0.016	CbGeAlD
Mirtazapine—HTR2A—vertebral column—malignant glioma	0.00211	0.0159	CbGeAlD
Mirtazapine—Cerebration impaired—Temozolomide—malignant glioma	0.00188	0.0121	CcSEcCtD
Mirtazapine—Myasthenia—Carmustine—malignant glioma	0.00182	0.0117	CcSEcCtD
Mirtazapine—Oral candidiasis—Carmustine—malignant glioma	0.00181	0.0116	CcSEcCtD
Mirtazapine—Aphasia—Carmustine—malignant glioma	0.00177	0.0114	CcSEcCtD
Mirtazapine—HTR2A—telencephalic ventricle—malignant glioma	0.00175	0.0132	CbGeAlD
Mirtazapine—Oral candidiasis—Temozolomide—malignant glioma	0.00174	0.0112	CcSEcCtD
Mirtazapine—Embolism—Temozolomide—malignant glioma	0.00173	0.0111	CcSEcCtD
Mirtazapine—Parosmia—Temozolomide—malignant glioma	0.00171	0.011	CcSEcCtD
Mirtazapine—Aphasia—Temozolomide—malignant glioma	0.00171	0.011	CcSEcCtD
Mirtazapine—Hypokinesia—Carmustine—malignant glioma	0.0017	0.0109	CcSEcCtD
Mirtazapine—Paranoia—Carmustine—malignant glioma	0.00168	0.0108	CcSEcCtD
Mirtazapine—Apathy—Temozolomide—malignant glioma	0.00155	0.00998	CcSEcCtD
Mirtazapine—Flat affect—Temozolomide—malignant glioma	0.00154	0.00989	CcSEcCtD
Mirtazapine—Stupor—Carmustine—malignant glioma	0.00154	0.00988	CcSEcCtD
Mirtazapine—HTR2A—pineal body—malignant glioma	0.00152	0.0114	CbGeAlD
Mirtazapine—HTR7—endothelium—malignant glioma	0.0015	0.0113	CbGeAlD
Mirtazapine—Menorrhagia—Temozolomide—malignant glioma	0.0015	0.00963	CcSEcCtD
Mirtazapine—Herpes zoster—Temozolomide—malignant glioma	0.00147	0.00947	CcSEcCtD
Mirtazapine—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00147	0.00947	CcSEcCtD
Mirtazapine—Coagulopathy—Temozolomide—malignant glioma	0.00142	0.00916	CcSEcCtD
Mirtazapine—Otitis media—Temozolomide—malignant glioma	0.00142	0.00916	CcSEcCtD
Mirtazapine—Memory impairment—Temozolomide—malignant glioma	0.00141	0.00908	CcSEcCtD
Mirtazapine—HTR7—blood vessel—malignant glioma	0.00139	0.0104	CbGeAlD
Mirtazapine—Petechiae—Temozolomide—malignant glioma	0.00135	0.00867	CcSEcCtD
Mirtazapine—Disturbance in attention—Temozolomide—malignant glioma	0.00128	0.00823	CcSEcCtD
Mirtazapine—Breast pain—Temozolomide—malignant glioma	0.00127	0.00817	CcSEcCtD
Mirtazapine—Amenorrhoea—Temozolomide—malignant glioma	0.00126	0.00811	CcSEcCtD
Mirtazapine—Thinking abnormal—Carmustine—malignant glioma	0.00125	0.00806	CcSEcCtD
Mirtazapine—HRH3—central nervous system—malignant glioma	0.00123	0.00929	CbGeAlD
Mirtazapine—HRH3—cerebellum—malignant glioma	0.00121	0.00908	CbGeAlD
Mirtazapine—Herpes simplex—Temozolomide—malignant glioma	0.0012	0.00774	CcSEcCtD
Mirtazapine—HTR3A—brainstem—malignant glioma	0.00117	0.00883	CbGeAlD
Mirtazapine—Coordination abnormal—Carmustine—malignant glioma	0.00117	0.00751	CcSEcCtD
Mirtazapine—Neck pain—Carmustine—malignant glioma	0.00116	0.00747	CcSEcCtD
Mirtazapine—Pulmonary embolism—Carmustine—malignant glioma	0.00115	0.00738	CcSEcCtD
Mirtazapine—Coordination abnormal—Temozolomide—malignant glioma	0.00113	0.00726	CcSEcCtD
Mirtazapine—Pulmonary embolism—Temozolomide—malignant glioma	0.00111	0.00713	CcSEcCtD
Mirtazapine—Vaginal inflammation—Temozolomide—malignant glioma	0.00111	0.00713	CcSEcCtD
Mirtazapine—Depressed level of consciousness—Carmustine—malignant glioma	0.00111	0.00712	CcSEcCtD
Mirtazapine—Urinary incontinence—Carmustine—malignant glioma	0.00111	0.00712	CcSEcCtD
Mirtazapine—Candida infection—Carmustine—malignant glioma	0.00109	0.00704	CcSEcCtD
Mirtazapine—Urinary incontinence—Temozolomide—malignant glioma	0.00107	0.00688	CcSEcCtD
Mirtazapine—Depressed level of consciousness—Temozolomide—malignant glioma	0.00107	0.00688	CcSEcCtD
Mirtazapine—Candida infection—Temozolomide—malignant glioma	0.00106	0.00681	CcSEcCtD
Mirtazapine—Coma—Carmustine—malignant glioma	0.00105	0.00674	CcSEcCtD
Mirtazapine—Vaginal infection—Temozolomide—malignant glioma	0.00105	0.00673	CcSEcCtD
Mirtazapine—Aplastic anaemia—Temozolomide—malignant glioma	0.00104	0.00669	CcSEcCtD
Mirtazapine—HTR3A—telencephalon—malignant glioma	0.00104	0.00783	CbGeAlD
Mirtazapine—Epinastine—CYP2B6—malignant glioma	0.00101	0.483	CrCbGaD
Mirtazapine—Mental disability—Carmustine—malignant glioma	0.000995	0.0064	CcSEcCtD
Mirtazapine—HRH3—brain—malignant glioma	0.000979	0.00738	CbGeAlD
Mirtazapine—SLC6A3—brainstem—malignant glioma	0.000976	0.00735	CbGeAlD
Mirtazapine—Phlebitis—Carmustine—malignant glioma	0.000966	0.00622	CcSEcCtD
Mirtazapine—DRD4—brain—malignant glioma	0.000966	0.00727	CbGeAlD
Mirtazapine—Mental disability—Temozolomide—malignant glioma	0.000962	0.00619	CcSEcCtD
Mirtazapine—Diabetes mellitus—Carmustine—malignant glioma	0.000957	0.00616	CcSEcCtD
Mirtazapine—HTR2C—brainstem—malignant glioma	0.000943	0.0071	CbGeAlD
Mirtazapine—Ear pain—Temozolomide—malignant glioma	0.000943	0.00607	CcSEcCtD
Mirtazapine—HTR2A—endothelium—malignant glioma	0.000938	0.00707	CbGeAlD
Mirtazapine—Eye pain—Carmustine—malignant glioma	0.000922	0.00593	CcSEcCtD
Mirtazapine—Gastroenteritis—Temozolomide—malignant glioma	0.000908	0.00584	CcSEcCtD
Mirtazapine—Deafness—Temozolomide—malignant glioma	0.000899	0.00578	CcSEcCtD
Mirtazapine—SLC6A4—brainstem—malignant glioma	0.000894	0.00673	CbGeAlD
Mirtazapine—Eye pain—Temozolomide—malignant glioma	0.000891	0.00573	CcSEcCtD
Mirtazapine—Amnesia—Carmustine—malignant glioma	0.000886	0.0057	CcSEcCtD
Mirtazapine—SLC6A3—telencephalon—malignant glioma	0.000866	0.00652	CbGeAlD
Mirtazapine—HTR2A—blood vessel—malignant glioma	0.000865	0.00652	CbGeAlD
Mirtazapine—Amnesia—Temozolomide—malignant glioma	0.000856	0.00551	CcSEcCtD
Mirtazapine—DRD3—central nervous system—malignant glioma	0.000855	0.00644	CbGeAlD
Mirtazapine—Dermatitis exfoliative—Temozolomide—malignant glioma	0.000853	0.00548	CcSEcCtD
Mirtazapine—Thirst—Temozolomide—malignant glioma	0.000845	0.00544	CcSEcCtD
Mirtazapine—HTR2C—telencephalon—malignant glioma	0.000837	0.0063	CbGeAlD
Mirtazapine—Hyponatraemia—Carmustine—malignant glioma	0.000836	0.00538	CcSEcCtD
Mirtazapine—Diplopia—Carmustine—malignant glioma	0.000833	0.00536	CcSEcCtD
Mirtazapine—ADRB1—telencephalon—malignant glioma	0.000821	0.00618	CbGeAlD
Mirtazapine—Diplopia—Temozolomide—malignant glioma	0.000805	0.00518	CcSEcCtD
Mirtazapine—Face oedema—Carmustine—malignant glioma	0.000804	0.00517	CcSEcCtD
Mirtazapine—HTR1A—brainstem—malignant glioma	0.000794	0.00598	CbGeAlD
Mirtazapine—SLC6A4—telencephalon—malignant glioma	0.000793	0.00597	CbGeAlD
Mirtazapine—Affect lability—Temozolomide—malignant glioma	0.000792	0.00509	CcSEcCtD
Mirtazapine—SLC6A2—brainstem—malignant glioma	0.000787	0.00593	CbGeAlD
Mirtazapine—HTR2B—telencephalon—malignant glioma	0.000786	0.00592	CbGeAlD
Mirtazapine—Ataxia—Carmustine—malignant glioma	0.000783	0.00504	CcSEcCtD
Mirtazapine—Face oedema—Temozolomide—malignant glioma	0.000777	0.005	CcSEcCtD
Mirtazapine—Liver function test abnormal—Carmustine—malignant glioma	0.000769	0.00494	CcSEcCtD
Mirtazapine—OPRK1—central nervous system—malignant glioma	0.000762	0.00574	CbGeAlD
Mirtazapine—Mood swings—Temozolomide—malignant glioma	0.000762	0.0049	CcSEcCtD
Mirtazapine—HTR7—brainstem—malignant glioma	0.000759	0.00571	CbGeAlD
Mirtazapine—Ataxia—Temozolomide—malignant glioma	0.000757	0.00487	CcSEcCtD
Mirtazapine—Dehydration—Temozolomide—malignant glioma	0.000748	0.00481	CcSEcCtD
Mirtazapine—OPRK1—cerebellum—malignant glioma	0.000745	0.00561	CbGeAlD
Mirtazapine—Dry skin—Temozolomide—malignant glioma	0.000737	0.00474	CcSEcCtD
Mirtazapine—Muscular weakness—Carmustine—malignant glioma	0.000734	0.00472	CcSEcCtD
Mirtazapine—ADRA1A—brainstem—malignant glioma	0.000732	0.00551	CbGeAlD
Mirtazapine—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.000724	0.00466	CcSEcCtD
Mirtazapine—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000724	0.00466	CcSEcCtD
Mirtazapine—DRD2—brainstem—malignant glioma	0.000717	0.0054	CbGeAlD
Mirtazapine—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00071	0.00456	CcSEcCtD
Mirtazapine—Muscular weakness—Temozolomide—malignant glioma	0.00071	0.00456	CcSEcCtD
Mirtazapine—HTR1A—telencephalon—malignant glioma	0.000704	0.0053	CbGeAlD
Mirtazapine—Abdominal distension—Temozolomide—malignant glioma	0.0007	0.0045	CcSEcCtD
Mirtazapine—SLC6A2—telencephalon—malignant glioma	0.000698	0.00526	CbGeAlD
Mirtazapine—DRD2—retina—malignant glioma	0.000692	0.00521	CbGeAlD
Mirtazapine—Pancytopenia—Carmustine—malignant glioma	0.000683	0.0044	CcSEcCtD
Mirtazapine—DRD3—brain—malignant glioma	0.000679	0.00511	CbGeAlD
Mirtazapine—Sweating increased—Temozolomide—malignant glioma	0.000677	0.00436	CcSEcCtD
Mirtazapine—HTR7—telencephalon—malignant glioma	0.000673	0.00507	CbGeAlD
Mirtazapine—Neutropenia—Carmustine—malignant glioma	0.000673	0.00433	CcSEcCtD
Mirtazapine—Bronchitis—Temozolomide—malignant glioma	0.000669	0.0043	CcSEcCtD
Mirtazapine—Pancytopenia—Temozolomide—malignant glioma	0.00066	0.00425	CcSEcCtD
Mirtazapine—HTR2C—medulla oblongata—malignant glioma	0.000658	0.00495	CbGeAlD
Mirtazapine—Neutropenia—Temozolomide—malignant glioma	0.00065	0.00418	CcSEcCtD
Mirtazapine—Dysuria—Temozolomide—malignant glioma	0.00065	0.00418	CcSEcCtD
Mirtazapine—ADRA1A—telencephalon—malignant glioma	0.000649	0.00489	CbGeAlD
Mirtazapine—Pneumonia—Carmustine—malignant glioma	0.000645	0.00415	CcSEcCtD
Mirtazapine—Pollakiuria—Temozolomide—malignant glioma	0.000642	0.00413	CcSEcCtD
Mirtazapine—Erectile dysfunction—Temozolomide—malignant glioma	0.00064	0.00412	CcSEcCtD
Mirtazapine—DRD2—telencephalon—malignant glioma	0.000636	0.00479	CbGeAlD
Mirtazapine—Photosensitivity reaction—Temozolomide—malignant glioma	0.000635	0.00408	CcSEcCtD
Mirtazapine—Weight increased—Temozolomide—malignant glioma	0.000633	0.00407	CcSEcCtD
Mirtazapine—Weight decreased—Temozolomide—malignant glioma	0.000629	0.00405	CcSEcCtD
Mirtazapine—Stomatitis—Carmustine—malignant glioma	0.000625	0.00402	CcSEcCtD
Mirtazapine—Urinary tract infection—Carmustine—malignant glioma	0.000624	0.00401	CcSEcCtD
Mirtazapine—Pneumonia—Temozolomide—malignant glioma	0.000624	0.00401	CcSEcCtD
Mirtazapine—SLC6A3—midbrain—malignant glioma	0.000622	0.00468	CbGeAlD
Mirtazapine—ADRA2C—telencephalon—malignant glioma	0.000619	0.00466	CbGeAlD
Mirtazapine—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000615	0.00395	CcSEcCtD
Mirtazapine—SLC6A3—spinal cord—malignant glioma	0.000607	0.00457	CbGeAlD
Mirtazapine—OPRK1—brain—malignant glioma	0.000605	0.00456	CbGeAlD
Mirtazapine—Stomatitis—Temozolomide—malignant glioma	0.000604	0.00389	CcSEcCtD
Mirtazapine—Urinary tract infection—Temozolomide—malignant glioma	0.000603	0.00388	CcSEcCtD
Mirtazapine—HTR2C—midbrain—malignant glioma	0.000601	0.00453	CbGeAlD
Mirtazapine—HTR3A—central nervous system—malignant glioma	0.000591	0.00445	CbGeAlD
Mirtazapine—Hepatobiliary disease—Temozolomide—malignant glioma	0.000586	0.00377	CcSEcCtD
Mirtazapine—HTR2C—spinal cord—malignant glioma	0.000586	0.00442	CbGeAlD
Mirtazapine—Mianserin—CYP2B6—malignant glioma	0.000582	0.279	CrCbGaD
Mirtazapine—Sinusitis—Temozolomide—malignant glioma	0.000582	0.00374	CcSEcCtD
Mirtazapine—Hallucination—Carmustine—malignant glioma	0.000573	0.00369	CcSEcCtD
Mirtazapine—Hypoaesthesia—Carmustine—malignant glioma	0.000573	0.00369	CcSEcCtD
Mirtazapine—SLC6A4—midbrain—malignant glioma	0.00057	0.00429	CbGeAlD
Mirtazapine—Oedema peripheral—Carmustine—malignant glioma	0.000567	0.00365	CcSEcCtD
Mirtazapine—Hepatitis—Temozolomide—malignant glioma	0.000557	0.00358	CcSEcCtD
Mirtazapine—SLC6A4—spinal cord—malignant glioma	0.000556	0.00419	CbGeAlD
Mirtazapine—Hypoaesthesia—Temozolomide—malignant glioma	0.000554	0.00356	CcSEcCtD
Mirtazapine—Hallucination—Temozolomide—malignant glioma	0.000554	0.00356	CcSEcCtD
Mirtazapine—Pharyngitis—Temozolomide—malignant glioma	0.000552	0.00355	CcSEcCtD
Mirtazapine—Urinary tract disorder—Temozolomide—malignant glioma	0.00055	0.00354	CcSEcCtD
Mirtazapine—SLC6A2—medulla oblongata—malignant glioma	0.000549	0.00413	CbGeAlD
Mirtazapine—Oedema peripheral—Temozolomide—malignant glioma	0.000548	0.00353	CcSEcCtD
Mirtazapine—Urethral disorder—Temozolomide—malignant glioma	0.000546	0.00351	CcSEcCtD
Mirtazapine—Eye disorder—Carmustine—malignant glioma	0.000538	0.00346	CcSEcCtD
Mirtazapine—HTR7—medulla oblongata—malignant glioma	0.000529	0.00398	CbGeAlD
Mirtazapine—Erythema multiforme—Temozolomide—malignant glioma	0.000526	0.00338	CcSEcCtD
Mirtazapine—Eye disorder—Temozolomide—malignant glioma	0.00052	0.00335	CcSEcCtD
Mirtazapine—Tinnitus—Temozolomide—malignant glioma	0.000519	0.00334	CcSEcCtD
Mirtazapine—Cardiac disorder—Temozolomide—malignant glioma	0.000517	0.00332	CcSEcCtD
Mirtazapine—HTR2A—embryo—malignant glioma	0.000516	0.00389	CbGeAlD
Mirtazapine—Arrhythmia—Carmustine—malignant glioma	0.000515	0.00331	CcSEcCtD
Mirtazapine—Alopecia—Carmustine—malignant glioma	0.000509	0.00327	CcSEcCtD
Mirtazapine—HTR1A—midbrain—malignant glioma	0.000506	0.00381	CbGeAlD
Mirtazapine—Angiopathy—Temozolomide—malignant glioma	0.000505	0.00325	CcSEcCtD
Mirtazapine—Mental disorder—Carmustine—malignant glioma	0.000505	0.00325	CcSEcCtD
Mirtazapine—HRH1—telencephalon—malignant glioma	0.000503	0.00379	CbGeAlD
Mirtazapine—Malnutrition—Carmustine—malignant glioma	0.000501	0.00322	CcSEcCtD
Mirtazapine—Chills—Temozolomide—malignant glioma	0.000499	0.00321	CcSEcCtD
Mirtazapine—Mianserin—SLC6A3—malignant glioma	0.000496	0.238	CrCbGaD
Mirtazapine—ADRA2A—telencephalon—malignant glioma	0.000494	0.00372	CbGeAlD
Mirtazapine—HTR1A—spinal cord—malignant glioma	0.000494	0.00372	CbGeAlD
Mirtazapine—SLC6A3—central nervous system—malignant glioma	0.000492	0.00371	CbGeAlD
Mirtazapine—Alopecia—Temozolomide—malignant glioma	0.000492	0.00316	CcSEcCtD
Mirtazapine—Mental disorder—Temozolomide—malignant glioma	0.000488	0.00314	CcSEcCtD
Mirtazapine—ADRA2C—medulla oblongata—malignant glioma	0.000486	0.00366	CbGeAlD
Mirtazapine—Back pain—Carmustine—malignant glioma	0.000485	0.00312	CcSEcCtD
Mirtazapine—Malnutrition—Temozolomide—malignant glioma	0.000485	0.00312	CcSEcCtD
Mirtazapine—HTR7—midbrain—malignant glioma	0.000483	0.00364	CbGeAlD
Mirtazapine—SLC6A3—cerebellum—malignant glioma	0.000481	0.00362	CbGeAlD
Mirtazapine—HTR2C—central nervous system—malignant glioma	0.000476	0.00358	CbGeAlD
Mirtazapine—Dysgeusia—Temozolomide—malignant glioma	0.000474	0.00305	CcSEcCtD
Mirtazapine—HTR2A—brainstem—malignant glioma	0.000473	0.00356	CbGeAlD
Mirtazapine—HTR7—spinal cord—malignant glioma	0.000472	0.00355	CbGeAlD
Mirtazapine—Tremor—Carmustine—malignant glioma	0.00047	0.00302	CcSEcCtD
Mirtazapine—HTR3A—brain—malignant glioma	0.00047	0.00354	CbGeAlD
Mirtazapine—Back pain—Temozolomide—malignant glioma	0.000469	0.00301	CcSEcCtD
Mirtazapine—ADRB1—central nervous system—malignant glioma	0.000467	0.00351	CbGeAlD
Mirtazapine—Anaemia—Carmustine—malignant glioma	0.000463	0.00298	CcSEcCtD
Mirtazapine—Agitation—Carmustine—malignant glioma	0.000461	0.00296	CcSEcCtD
Mirtazapine—DRD2—midbrain—malignant glioma	0.000457	0.00344	CbGeAlD
Mirtazapine—HTR2A—retina—malignant glioma	0.000456	0.00344	CbGeAlD
Mirtazapine—Tremor—Temozolomide—malignant glioma	0.000454	0.00292	CcSEcCtD
Mirtazapine—SLC6A4—central nervous system—malignant glioma	0.000451	0.0034	CbGeAlD
Mirtazapine—Ill-defined disorder—Temozolomide—malignant glioma	0.00045	0.00289	CcSEcCtD
Mirtazapine—Leukopenia—Carmustine—malignant glioma	0.000449	0.00289	CcSEcCtD
Mirtazapine—Anaemia—Temozolomide—malignant glioma	0.000448	0.00288	CcSEcCtD
Mirtazapine—HTR2B—central nervous system—malignant glioma	0.000447	0.00336	CbGeAlD
Mirtazapine—Agitation—Temozolomide—malignant glioma	0.000445	0.00286	CcSEcCtD
Mirtazapine—ADRA2C—midbrain—malignant glioma	0.000444	0.00335	CbGeAlD
Mirtazapine—Malaise—Temozolomide—malignant glioma	0.000437	0.00281	CcSEcCtD
Mirtazapine—Vertigo—Temozolomide—malignant glioma	0.000435	0.0028	CcSEcCtD
Mirtazapine—Convulsion—Carmustine—malignant glioma	0.000434	0.00279	CcSEcCtD
Mirtazapine—Leukopenia—Temozolomide—malignant glioma	0.000434	0.00279	CcSEcCtD
Mirtazapine—ADRA2C—spinal cord—malignant glioma	0.000434	0.00326	CbGeAlD
Mirtazapine—Hypertension—Carmustine—malignant glioma	0.000433	0.00278	CcSEcCtD
Mirtazapine—CYP2D6—brainstem—malignant glioma	0.000431	0.00325	CbGeAlD
Mirtazapine—Palpitations—Temozolomide—malignant glioma	0.000428	0.00275	CcSEcCtD
Mirtazapine—Chest pain—Carmustine—malignant glioma	0.000427	0.00275	CcSEcCtD
Mirtazapine—Myalgia—Carmustine—malignant glioma	0.000427	0.00275	CcSEcCtD
Mirtazapine—Anxiety—Carmustine—malignant glioma	0.000425	0.00274	CcSEcCtD
Mirtazapine—Cough—Temozolomide—malignant glioma	0.000423	0.00272	CcSEcCtD
Mirtazapine—HTR2A—telencephalon—malignant glioma	0.00042	0.00316	CbGeAlD
Mirtazapine—Convulsion—Temozolomide—malignant glioma	0.00042	0.0027	CcSEcCtD
Mirtazapine—Hypertension—Temozolomide—malignant glioma	0.000418	0.00269	CcSEcCtD
Mirtazapine—Confusional state—Carmustine—malignant glioma	0.000413	0.00265	CcSEcCtD
Mirtazapine—Arthralgia—Temozolomide—malignant glioma	0.000412	0.00265	CcSEcCtD
Mirtazapine—Myalgia—Temozolomide—malignant glioma	0.000412	0.00265	CcSEcCtD
Mirtazapine—Anxiety—Temozolomide—malignant glioma	0.000411	0.00264	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00041	0.00263	CcSEcCtD
Mirtazapine—Oedema—Carmustine—malignant glioma	0.000409	0.00263	CcSEcCtD
Mirtazapine—Discomfort—Temozolomide—malignant glioma	0.000408	0.00262	CcSEcCtD
Mirtazapine—Infection—Carmustine—malignant glioma	0.000407	0.00261	CcSEcCtD
Mirtazapine—Dry mouth—Temozolomide—malignant glioma	0.000403	0.00259	CcSEcCtD
Mirtazapine—Thrombocytopenia—Carmustine—malignant glioma	0.000401	0.00258	CcSEcCtD
Mirtazapine—HTR1A—central nervous system—malignant glioma	0.0004	0.00301	CbGeAlD
Mirtazapine—Tachycardia—Carmustine—malignant glioma	0.000399	0.00257	CcSEcCtD
Mirtazapine—Confusional state—Temozolomide—malignant glioma	0.000399	0.00256	CcSEcCtD
Mirtazapine—SLC6A2—central nervous system—malignant glioma	0.000397	0.00299	CbGeAlD
Mirtazapine—Oedema—Temozolomide—malignant glioma	0.000395	0.00254	CcSEcCtD
Mirtazapine—Infection—Temozolomide—malignant glioma	0.000393	0.00253	CcSEcCtD
Mirtazapine—HTR1A—cerebellum—malignant glioma	0.000391	0.00295	CbGeAlD
Mirtazapine—SLC6A3—brain—malignant glioma	0.000391	0.00294	CbGeAlD
Mirtazapine—Anorexia—Carmustine—malignant glioma	0.00039	0.00251	CcSEcCtD
Mirtazapine—ADRA2A—medulla oblongata—malignant glioma	0.000388	0.00292	CbGeAlD
Mirtazapine—Nervous system disorder—Temozolomide—malignant glioma	0.000388	0.00249	CcSEcCtD
Mirtazapine—Thrombocytopenia—Temozolomide—malignant glioma	0.000387	0.00249	CcSEcCtD
Mirtazapine—Skin disorder—Temozolomide—malignant glioma	0.000384	0.00247	CcSEcCtD
Mirtazapine—HTR7—central nervous system—malignant glioma	0.000383	0.00288	CbGeAlD
Mirtazapine—CYP2D6—telencephalon—malignant glioma	0.000382	0.00288	CbGeAlD
Mirtazapine—Hypotension—Carmustine—malignant glioma	0.000382	0.00246	CcSEcCtD
Mirtazapine—Hyperhidrosis—Temozolomide—malignant glioma	0.000382	0.00246	CcSEcCtD
Mirtazapine—HTR2C—brain—malignant glioma	0.000378	0.00284	CbGeAlD
Mirtazapine—Anorexia—Temozolomide—malignant glioma	0.000377	0.00242	CcSEcCtD
Mirtazapine—HTR7—cerebellum—malignant glioma	0.000374	0.00282	CbGeAlD
Mirtazapine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000373	0.0024	CcSEcCtD
Mirtazapine—ADRB1—brain—malignant glioma	0.000371	0.00279	CbGeAlD
Mirtazapine—Insomnia—Carmustine—malignant glioma	0.00037	0.00238	CcSEcCtD
Mirtazapine—ADRA1A—central nervous system—malignant glioma	0.000369	0.00278	CbGeAlD
Mirtazapine—Paraesthesia—Carmustine—malignant glioma	0.000367	0.00236	CcSEcCtD
Mirtazapine—Dyspnoea—Carmustine—malignant glioma	0.000365	0.00235	CcSEcCtD
Mirtazapine—Somnolence—Carmustine—malignant glioma	0.000364	0.00234	CcSEcCtD
Mirtazapine—DRD2—central nervous system—malignant glioma	0.000362	0.00272	CbGeAlD
Mirtazapine—ADRA1A—cerebellum—malignant glioma	0.000361	0.00272	CbGeAlD
Mirtazapine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00036	0.00232	CcSEcCtD
Mirtazapine—SLC6A4—brain—malignant glioma	0.000358	0.0027	CbGeAlD
Mirtazapine—Insomnia—Temozolomide—malignant glioma	0.000358	0.0023	CcSEcCtD
Mirtazapine—Decreased appetite—Carmustine—malignant glioma	0.000356	0.00229	CcSEcCtD
Mirtazapine—Paraesthesia—Temozolomide—malignant glioma	0.000355	0.00228	CcSEcCtD
Mirtazapine—HTR2B—brain—malignant glioma	0.000355	0.00267	CbGeAlD
Mirtazapine—ADRA2A—midbrain—malignant glioma	0.000355	0.00267	CbGeAlD
Mirtazapine—DRD2—cerebellum—malignant glioma	0.000354	0.00266	CbGeAlD
Mirtazapine—Gastrointestinal disorder—Carmustine—malignant glioma	0.000353	0.00227	CcSEcCtD
Mirtazapine—Dyspnoea—Temozolomide—malignant glioma	0.000353	0.00227	CcSEcCtD
Mirtazapine—ADRA2C—central nervous system—malignant glioma	0.000352	0.00265	CbGeAlD
Mirtazapine—Somnolence—Temozolomide—malignant glioma	0.000352	0.00226	CcSEcCtD
Mirtazapine—Constipation—Carmustine—malignant glioma	0.00035	0.00225	CcSEcCtD
Mirtazapine—Pain—Carmustine—malignant glioma	0.00035	0.00225	CcSEcCtD
Mirtazapine—Dyspepsia—Temozolomide—malignant glioma	0.000348	0.00224	CcSEcCtD
Mirtazapine—ADRA2A—spinal cord—malignant glioma	0.000346	0.0026	CbGeAlD
Mirtazapine—ADRA2C—cerebellum—malignant glioma	0.000344	0.00259	CbGeAlD
Mirtazapine—Decreased appetite—Temozolomide—malignant glioma	0.000344	0.00221	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000341	0.0022	CcSEcCtD
Mirtazapine—Fatigue—Temozolomide—malignant glioma	0.000341	0.00219	CcSEcCtD
Mirtazapine—Pain—Temozolomide—malignant glioma	0.000338	0.00218	CcSEcCtD
Mirtazapine—Constipation—Temozolomide—malignant glioma	0.000338	0.00218	CcSEcCtD
Mirtazapine—Feeling abnormal—Carmustine—malignant glioma	0.000337	0.00217	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Carmustine—malignant glioma	0.000335	0.00215	CcSEcCtD
Mirtazapine—HTR2A—medulla oblongata—malignant glioma	0.00033	0.00248	CbGeAlD
Mirtazapine—Feeling abnormal—Temozolomide—malignant glioma	0.000326	0.0021	CcSEcCtD
Mirtazapine—Abdominal pain—Carmustine—malignant glioma	0.000323	0.00208	CcSEcCtD
Mirtazapine—Body temperature increased—Carmustine—malignant glioma	0.000323	0.00208	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Temozolomide—malignant glioma	0.000323	0.00208	CcSEcCtD
Mirtazapine—HTR1A—brain—malignant glioma	0.000318	0.00239	CbGeAlD
Mirtazapine—SLC6A2—brain—malignant glioma	0.000315	0.00237	CbGeAlD
Mirtazapine—Urticaria—Temozolomide—malignant glioma	0.000314	0.00202	CcSEcCtD
Mirtazapine—Abdominal pain—Temozolomide—malignant glioma	0.000313	0.00201	CcSEcCtD
Mirtazapine—Body temperature increased—Temozolomide—malignant glioma	0.000313	0.00201	CcSEcCtD
Mirtazapine—HTR7—brain—malignant glioma	0.000304	0.00229	CbGeAlD
Mirtazapine—HTR2A—midbrain—malignant glioma	0.000301	0.00227	CbGeAlD
Mirtazapine—Hypersensitivity—Carmustine—malignant glioma	0.000301	0.00194	CcSEcCtD
Mirtazapine—HTR2A—spinal cord—malignant glioma	0.000294	0.00221	CbGeAlD
Mirtazapine—Asthenia—Carmustine—malignant glioma	0.000294	0.00189	CcSEcCtD
Mirtazapine—ADRA1A—brain—malignant glioma	0.000293	0.00221	CbGeAlD
Mirtazapine—Hypersensitivity—Temozolomide—malignant glioma	0.000291	0.00187	CcSEcCtD
Mirtazapine—DRD2—brain—malignant glioma	0.000287	0.00216	CbGeAlD
Mirtazapine—HRH1—central nervous system—malignant glioma	0.000286	0.00215	CbGeAlD
Mirtazapine—Asthenia—Temozolomide—malignant glioma	0.000284	0.00182	CcSEcCtD
Mirtazapine—ADRA2A—central nervous system—malignant glioma	0.000281	0.00211	CbGeAlD
Mirtazapine—Diarrhoea—Carmustine—malignant glioma	0.00028	0.0018	CcSEcCtD
Mirtazapine—Pruritus—Temozolomide—malignant glioma	0.00028	0.0018	CcSEcCtD
Mirtazapine—ADRA2C—brain—malignant glioma	0.000279	0.0021	CbGeAlD
Mirtazapine—ADRA2A—cerebellum—malignant glioma	0.000274	0.00207	CbGeAlD
Mirtazapine—Dizziness—Carmustine—malignant glioma	0.000271	0.00174	CcSEcCtD
Mirtazapine—Diarrhoea—Temozolomide—malignant glioma	0.000271	0.00174	CcSEcCtD
Mirtazapine—Dizziness—Temozolomide—malignant glioma	0.000261	0.00168	CcSEcCtD
Mirtazapine—Vomiting—Carmustine—malignant glioma	0.00026	0.00167	CcSEcCtD
Mirtazapine—CYP2C8—brain—malignant glioma	0.000259	0.00195	CbGeAlD
Mirtazapine—Rash—Carmustine—malignant glioma	0.000258	0.00166	CcSEcCtD
Mirtazapine—Dermatitis—Carmustine—malignant glioma	0.000258	0.00166	CcSEcCtD
Mirtazapine—Headache—Carmustine—malignant glioma	0.000256	0.00165	CcSEcCtD
Mirtazapine—Vomiting—Temozolomide—malignant glioma	0.000251	0.00162	CcSEcCtD
Mirtazapine—Rash—Temozolomide—malignant glioma	0.000249	0.0016	CcSEcCtD
Mirtazapine—Dermatitis—Temozolomide—malignant glioma	0.000249	0.0016	CcSEcCtD
Mirtazapine—Headache—Temozolomide—malignant glioma	0.000248	0.00159	CcSEcCtD
Mirtazapine—Nausea—Carmustine—malignant glioma	0.000243	0.00156	CcSEcCtD
Mirtazapine—HTR2A—central nervous system—malignant glioma	0.000239	0.0018	CbGeAlD
Mirtazapine—Nausea—Temozolomide—malignant glioma	0.000235	0.00151	CcSEcCtD
Mirtazapine—HTR2A—cerebellum—malignant glioma	0.000233	0.00176	CbGeAlD
Mirtazapine—HRH1—brain—malignant glioma	0.000227	0.00171	CbGeAlD
Mirtazapine—ADRA2A—brain—malignant glioma	0.000223	0.00168	CbGeAlD
Mirtazapine—CYP3A4—central nervous system—malignant glioma	0.000221	0.00166	CbGeAlD
Mirtazapine—CYP2D6—central nervous system—malignant glioma	0.000217	0.00164	CbGeAlD
Mirtazapine—CYP2D6—cerebellum—malignant glioma	0.000212	0.0016	CbGeAlD
Mirtazapine—HTR2A—brain—malignant glioma	0.000189	0.00143	CbGeAlD
Mirtazapine—CYP2D6—brain—malignant glioma	0.000173	0.0013	CbGeAlD
Mirtazapine—ADRA1A—Signaling Pathways—FGF2—malignant glioma	5.26e-06	4.59e-05	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—AKT1—malignant glioma	5.26e-06	4.58e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—MYC—malignant glioma	5.25e-06	4.58e-05	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—AKT1—malignant glioma	5.23e-06	4.56e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CASP3—malignant glioma	5.21e-06	4.54e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL2—malignant glioma	5.2e-06	4.53e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CASP3—malignant glioma	5.18e-06	4.52e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL2—malignant glioma	5.17e-06	4.51e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—NCOR1—malignant glioma	5.17e-06	4.5e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—KRAS—malignant glioma	5.15e-06	4.49e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MMP9—malignant glioma	5.15e-06	4.49e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—EGFR—malignant glioma	5.14e-06	4.48e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	5.13e-06	4.47e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—PTEN—malignant glioma	5.12e-06	4.46e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MDM2—malignant glioma	5.11e-06	4.46e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PIK3CD—malignant glioma	5.11e-06	4.45e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—RAF1—malignant glioma	5.09e-06	4.44e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—AKT1—malignant glioma	5.09e-06	4.44e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—VEGFA—malignant glioma	5.07e-06	4.42e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—KRAS—malignant glioma	5.07e-06	4.42e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—PIK3CA—malignant glioma	5.06e-06	4.41e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—PIK3CA—malignant glioma	5.05e-06	4.4e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CASP3—malignant glioma	5.04e-06	4.39e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—ERBB2—malignant glioma	5.04e-06	4.39e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—PIK3CA—malignant glioma	5.04e-06	4.39e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MMP9—malignant glioma	5.03e-06	4.39e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL2—malignant glioma	5.03e-06	4.39e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MDM2—malignant glioma	5.03e-06	4.38e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—STAT3—malignant glioma	5.02e-06	4.38e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MDM2—malignant glioma	5.02e-06	4.37e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—MYC—malignant glioma	5.02e-06	4.37e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—RAF1—malignant glioma	5.01e-06	4.37e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—PTEN—malignant glioma	5.01e-06	4.36e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—RAF1—malignant glioma	5e-06	4.36e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—KRAS—malignant glioma	5e-06	4.36e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—AKT1—malignant glioma	4.99e-06	4.35e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PIK3CB—malignant glioma	4.97e-06	4.34e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—CAV1—malignant glioma	4.97e-06	4.33e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—ERBB2—malignant glioma	4.96e-06	4.32e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—ERBB2—malignant glioma	4.95e-06	4.31e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—PIK3CA—malignant glioma	4.94e-06	4.31e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—CAV1—malignant glioma	4.93e-06	4.3e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MDM2—malignant glioma	4.92e-06	4.29e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MMP9—malignant glioma	4.92e-06	4.29e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—RAF1—malignant glioma	4.91e-06	4.28e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—EGFR—malignant glioma	4.91e-06	4.28e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MMP9—malignant glioma	4.9e-06	4.27e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—PTEN—malignant glioma	4.89e-06	4.27e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PIK3CB—malignant glioma	4.89e-06	4.27e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—FGF2—malignant glioma	4.89e-06	4.26e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—AKT1—malignant glioma	4.88e-06	4.26e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PIK3CB—malignant glioma	4.88e-06	4.26e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—PTEN—malignant glioma	4.87e-06	4.24e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—ERBB2—malignant glioma	4.85e-06	4.23e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—KRAS—malignant glioma	4.85e-06	4.23e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PIK3CD—malignant glioma	4.85e-06	4.23e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PIK3CB—malignant glioma	4.79e-06	4.18e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CXCL8—malignant glioma	4.78e-06	4.17e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—AKT1—malignant glioma	4.77e-06	4.16e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MMP9—malignant glioma	4.76e-06	4.15e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—AKT1—malignant glioma	4.75e-06	4.14e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—PTEN—malignant glioma	4.74e-06	4.13e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—PIK3CA—malignant glioma	4.73e-06	4.13e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.71e-06	4.1e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CXCL8—malignant glioma	4.7e-06	4.1e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CXCL8—malignant glioma	4.69e-06	4.09e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—MYC—malignant glioma	4.67e-06	4.07e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—PIK3CA—malignant glioma	4.66e-06	4.06e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—KRAS—malignant glioma	4.63e-06	4.04e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—VEGFA—malignant glioma	4.62e-06	4.03e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—AKT1—malignant glioma	4.62e-06	4.03e-05	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—AKT1—malignant glioma	4.62e-06	4.02e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	4.6e-06	4.01e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PTEN—malignant glioma	4.6e-06	4.01e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	4.59e-06	4e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—TP53—malignant glioma	4.58e-06	3.99e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—STAT3—malignant glioma	4.58e-06	3.99e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MDM2—malignant glioma	4.58e-06	3.99e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CASP3—malignant glioma	4.57e-06	3.99e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL2—malignant glioma	4.57e-06	3.98e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—EGFR—malignant glioma	4.56e-06	3.98e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—RAF1—malignant glioma	4.56e-06	3.97e-05	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	4.54e-06	3.96e-05	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—AKT1—malignant glioma	4.53e-06	3.95e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CG—malignant glioma	4.53e-06	3.95e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—VEGFA—malignant glioma	4.52e-06	3.94e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	4.51e-06	3.93e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TP53—malignant glioma	4.51e-06	3.93e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CASP3—malignant glioma	4.5e-06	3.92e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL2—malignant glioma	4.49e-06	3.92e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CASP3—malignant glioma	4.49e-06	3.91e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CG—malignant glioma	4.49e-06	3.91e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL2—malignant glioma	4.48e-06	3.91e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—STAT3—malignant glioma	4.48e-06	3.9e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—PIK3CA—malignant glioma	4.46e-06	3.89e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	4.45e-06	3.88e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	4.45e-06	3.88e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—VEGFA—malignant glioma	4.42e-06	3.85e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CASP3—malignant glioma	4.41e-06	3.84e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL2—malignant glioma	4.4e-06	3.84e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—VEGFA—malignant glioma	4.4e-06	3.83e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—STAT3—malignant glioma	4.38e-06	3.82e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PPARG—malignant glioma	4.37e-06	3.81e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—STAT3—malignant glioma	4.35e-06	3.8e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GSTP1—malignant glioma	4.34e-06	3.78e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PPARG—malignant glioma	4.33e-06	3.78e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MMP9—malignant glioma	4.32e-06	3.77e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TP53—malignant glioma	4.31e-06	3.76e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—KRAS—malignant glioma	4.31e-06	3.76e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PTEN—malignant glioma	4.3e-06	3.75e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	4.28e-06	3.73e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—VEGFA—malignant glioma	4.28e-06	3.73e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—PIK3CA—malignant glioma	4.26e-06	3.71e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MMP9—malignant glioma	4.25e-06	3.71e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MYC—malignant glioma	4.25e-06	3.71e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MMP9—malignant glioma	4.24e-06	3.7e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—STAT3—malignant glioma	4.24e-06	3.69e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PTEN—malignant glioma	4.23e-06	3.69e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PIK3CB—malignant glioma	4.23e-06	3.68e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CAT—malignant glioma	4.22e-06	3.68e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PTEN—malignant glioma	4.22e-06	3.68e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—CAV1—malignant glioma	4.21e-06	3.67e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—AKT1—malignant glioma	4.19e-06	3.65e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTGS2—malignant glioma	4.19e-06	3.65e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MMP9—malignant glioma	4.16e-06	3.63e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MYC—malignant glioma	4.16e-06	3.63e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—EGFR—malignant glioma	4.16e-06	3.63e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PTEN—malignant glioma	4.14e-06	3.61e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	4.13e-06	3.6e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—AKT1—malignant glioma	4.12e-06	3.6e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TP53—malignant glioma	4.12e-06	3.59e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—AKT1—malignant glioma	4.12e-06	3.59e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CASP3—malignant glioma	4.09e-06	3.57e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL2—malignant glioma	4.09e-06	3.56e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—EGFR—malignant glioma	4.07e-06	3.55e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MYC—malignant glioma	4.07e-06	3.55e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MYC—malignant glioma	4.05e-06	3.53e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	4.04e-06	3.52e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.02e-06	3.51e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PIK3CA—malignant glioma	4e-06	3.48e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—NCOR1—malignant glioma	3.99e-06	3.48e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CD—malignant glioma	3.98e-06	3.47e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—EGFR—malignant glioma	3.98e-06	3.47e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—PIK3CA—malignant glioma	3.96e-06	3.45e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—EGFR—malignant glioma	3.96e-06	3.45e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CD—malignant glioma	3.95e-06	3.44e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MYC—malignant glioma	3.94e-06	3.43e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—KRAS—malignant glioma	3.93e-06	3.43e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—VEGFA—malignant glioma	3.88e-06	3.38e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MMP9—malignant glioma	3.87e-06	3.37e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—AKT1—malignant glioma	3.87e-06	3.37e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—EGFR—malignant glioma	3.85e-06	3.36e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PTEN—malignant glioma	3.85e-06	3.35e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—KRAS—malignant glioma	3.84e-06	3.35e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—STAT3—malignant glioma	3.84e-06	3.35e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CG—malignant glioma	3.84e-06	3.34e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TP53—malignant glioma	3.83e-06	3.34e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—VEGFA—malignant glioma	3.82e-06	3.33e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—VEGFA—malignant glioma	3.81e-06	3.32e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—AKT1—malignant glioma	3.81e-06	3.32e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—STAT3—malignant glioma	3.78e-06	3.3e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—STAT3—malignant glioma	3.77e-06	3.29e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—KRAS—malignant glioma	3.76e-06	3.28e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	3.75e-06	3.27e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	3.74e-06	3.26e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—KRAS—malignant glioma	3.74e-06	3.26e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—STAT3—malignant glioma	3.7e-06	3.23e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PPARG—malignant glioma	3.7e-06	3.23e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTEN—malignant glioma	3.65e-06	3.18e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—AKT1—malignant glioma	3.64e-06	3.18e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—KRAS—malignant glioma	3.64e-06	3.17e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—PIK3CA—malignant glioma	3.61e-06	3.15e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MYC—malignant glioma	3.57e-06	3.11e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—PIK3CA—malignant glioma	3.53e-06	3.08e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MYC—malignant glioma	3.51e-06	3.06e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MYC—malignant glioma	3.51e-06	3.06e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—EGFR—malignant glioma	3.49e-06	3.04e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TP53—malignant glioma	3.49e-06	3.04e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—AKT1—malignant glioma	3.48e-06	3.03e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	3.47e-06	3.03e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CB—malignant glioma	3.47e-06	3.02e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	3.45e-06	3.01e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MYC—malignant glioma	3.44e-06	3e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—STAT3—malignant glioma	3.44e-06	3e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CB—malignant glioma	3.44e-06	3e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTGS2—malignant glioma	3.44e-06	3e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—EGFR—malignant glioma	3.44e-06	3e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	3.43e-06	2.99e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—EGFR—malignant glioma	3.43e-06	2.99e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TP53—malignant glioma	3.42e-06	2.98e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTGS2—malignant glioma	3.41e-06	2.97e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CD—malignant glioma	3.37e-06	2.94e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—EGFR—malignant glioma	3.37e-06	2.93e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—PIK3CA—malignant glioma	3.34e-06	2.91e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TP53—malignant glioma	3.34e-06	2.91e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TP53—malignant glioma	3.32e-06	2.9e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—KRAS—malignant glioma	3.3e-06	2.88e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—AKT1—malignant glioma	3.26e-06	2.85e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CAV1—malignant glioma	3.25e-06	2.83e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—KRAS—malignant glioma	3.25e-06	2.83e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PIK3CA—malignant glioma	3.25e-06	2.83e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—KRAS—malignant glioma	3.24e-06	2.82e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—AKT1—malignant glioma	3.24e-06	2.82e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TP53—malignant glioma	3.23e-06	2.82e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MYC—malignant glioma	3.2e-06	2.79e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—KRAS—malignant glioma	3.18e-06	2.77e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—EGFR—malignant glioma	3.13e-06	2.73e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PIK3CA—malignant glioma	3.03e-06	2.64e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTEN—malignant glioma	3e-06	2.61e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	2.98e-06	2.6e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PIK3CA—malignant glioma	2.98e-06	2.59e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTEN—malignant glioma	2.97e-06	2.59e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.96e-06	2.58e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—KRAS—malignant glioma	2.95e-06	2.57e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—AKT1—malignant glioma	2.95e-06	2.57e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CB—malignant glioma	2.94e-06	2.56e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TP53—malignant glioma	2.93e-06	2.56e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	2.92e-06	2.55e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTGS2—malignant glioma	2.91e-06	2.54e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TP53—malignant glioma	2.89e-06	2.52e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—AKT1—malignant glioma	2.88e-06	2.51e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TP53—malignant glioma	2.88e-06	2.51e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PPARG—malignant glioma	2.86e-06	2.49e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TP53—malignant glioma	2.83e-06	2.46e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—AKT1—malignant glioma	2.82e-06	2.46e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—AKT1—malignant glioma	2.81e-06	2.45e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—AKT1—malignant glioma	2.73e-06	2.38e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	2.71e-06	2.37e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—AKT1—malignant glioma	2.65e-06	2.31e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TP53—malignant glioma	2.63e-06	2.29e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.6e-06	2.27e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PIK3CA—malignant glioma	2.58e-06	2.25e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTEN—malignant glioma	2.54e-06	2.21e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—AKT1—malignant glioma	2.48e-06	2.16e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—AKT1—malignant glioma	2.44e-06	2.12e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—AKT1—malignant glioma	2.43e-06	2.12e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—AKT1—malignant glioma	2.39e-06	2.08e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CB—malignant glioma	2.27e-06	1.98e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTGS2—malignant glioma	2.25e-06	1.96e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—AKT1—malignant glioma	2.22e-06	1.93e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.11e-06	1.84e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—AKT1—malignant glioma	2.1e-06	1.83e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PIK3CA—malignant glioma	2.1e-06	1.83e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTEN—malignant glioma	1.96e-06	1.71e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.79e-06	1.56e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—AKT1—malignant glioma	1.73e-06	1.51e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—AKT1—malignant glioma	1.71e-06	1.49e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—AKT1—malignant glioma	1.46e-06	1.28e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.38e-06	1.21e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—AKT1—malignant glioma	1.13e-06	9.85e-06	CbGpPWpGaD
